1. Home
  2. TORO vs ANIK Comparison

TORO vs ANIK Comparison

Compare TORO & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Corp.

TORO

Toro Corp.

HOLD

Current Price

$4.96

Market Cap

173.8M

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$15.90

Market Cap

200.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TORO
ANIK
Founded
2022
1983
Country
Cyprus
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.8M
200.9M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
TORO
ANIK
Price
$4.96
$15.90
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
33.7K
63.8K
Earning Date
04-15-2026
04-29-2026
Dividend Yield
36.86%
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$7.90
52 Week High
$8.50
$16.24

Technical Indicators

Market Signals
Indicator
TORO
ANIK
Relative Strength Index (RSI) 45.83 65.35
Support Level $4.89 $13.88
Resistance Level $5.85 N/A
Average True Range (ATR) 0.28 0.50
MACD 0.00 0.13
Stochastic Oscillator 36.99 99.32

Price Performance

Historical Comparison
TORO
ANIK

About TORO Toro Corp.

Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: